Prevalence, incidence and mortality of diagnosed diabetes: Evidence from an Italian population-based study

Diabetic Medicine

Volumn 29, Issue 3, 2012, Pages 385-392

  Monesi, L ^a   Baviera, M ^a   Marzona, I ^a   Avanzini, F ^a   Monesi, G ^b   Nobili, A ^c   Tettamanti, M ^a   Cortesi, L ^a   Riva, E ^a   Fortino, I ^d   Bortolotti, A ^d   Fontana, G ^d   Merlino, L ^d   Roncaglioni, M C ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c Laboratory of Quality Assessment of Geriatric Therapies and Services   (Italy)

^d Regional Health Ministry   (Italy)

Author keywords

Diabetes; Incidence; Mortality; Prevalence

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEALTH PLANNING; HUMANS; INCIDENCE; INFANT; ITALY; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857280494     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03446.x     Document Type: Article

References (30)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. WHO. Diabetes Fact Sheet no.312. Geneva: World Health Organization, 2006. Available at Last accessed 11 November 2010.
3. Halanych JH, Safford MM, Keys WC, Person SD, Shikany JM, Kim Yi et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 2007; 30: 2999-3004.
4. Colagiuri S, Borch-Johnsen K, Glümer C, Vistisen D. There really is an epidemic of type2 diabetes? Diabetologia 2005; 48: 1459-1463.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
6. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care 2004; 27: 2806-2812.
7. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
8. Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmacoepidemiological database. Lancet 2003; 362: 537-538.
9. Cartensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, on behalf of the steering group of the National Diabetes Register. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008; 51: 2187-2196.
10. Evans JMM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Diabetologia 2007; 50: 729-732.
11. Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S et al. Incidence of type1 and type2 diabetes in adults aged 30-49years. Diabetes Care 2005; 28: 2613-2619.
12. Brocco S, Visentin C, Fedeli U, Schievano E, Avogaro A, Andretta M et al. Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc Diabetology 2007; 6: 5.
13. Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P, Allemand H. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab 2008; 34: 266-272.
14. Ricci P, Blotière P-O, Weill A, Simon D, Tuppin P, Ricordeau P et al. Diabète traité: quelles évolutions entre 2000 et 2009 en France (Treated diabetes: which trends between 2000 and 2009 in France?) BEH 2010; 42-43: 425-431. Available at Last accessed 15 February 2011.
15. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based-study. Lancet 2007; 369: 750-756.
16. Green A, Støvring H, Andersen M, Beck-Nielsen H. The epidemic of type2 diabetes is a statistical artefact. Diabetologia 2005; 48: 1456-1458.
17. Mazzaglia G, Yurgin N, Boye KS, Trifirò G, Cottrell S, Allen E et al. Prevalence and antihyperglycemic prescribing trends for patients with type2 diabetes in Italy: a 4-year retrospective study from national primary care data. Pharmacol Res 2008; 57: 358-363.
18. CINECA Osservatorio. ARNO Diabete-Analisi di dieci anni di prescrizioni (ARNO Diabetes-Analysis of ten years of prescriptions. Official Report 2007). Rapporto 2007, Vol.XI. Casalecchio di Reno (BO), Italy: CINECA Consortium of universities, 2007.
19. Bruno G, Merletti F, Bargero G, Melis D, Masi I, Ianni A et al. Changes over time in the prevalence and quality of care of type2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 2008; 18: 39-45.
20. Lapolla A, Dalfrà MG, Lencioni C, Di Cianni C. Epidemiology of diabetes in pregnancy: a review of Italian data. Diabetes Nutr Metab 2004; 17: 358-367.
21. Ringborg A, Lindgren P, Martinell M, Yin DD, Schön S, Stalhammar J. Prevalence and incidence of Type2 diabetes and its complications 1996-2003-estimates from a Swedish population-based study. Diabet Med 2008; 25: 1178-1186.
22. Gulliford MC, Charlton J. Is relative mortality of type2 diabetes mellitus decreasing? Am J Epidemiol 2009; 169: 455-461.
23. Jansson SPO, Andersson DKG, Svärsudd K. Mortality trends in subjects with and without diabetes during 33years of follow-up. Diabetes Care 2010; 33: 551-556.
24. Gregg EW, Gu Q, Cheng YJ, Venkat Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007; 147: 149-155.
25. Imperatore G, Cadwell BL, Geiss L, Saadine JB, Williams DE, Ford ES et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 2004; 160: 531-539.
26. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. J Am Med Assoc 1988; 260: 3456-3460.
27. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L et al., for the DIAMOND Study Group. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004; 43: 771-777.
28. Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Counting drugs to understand disease: the case of measuring the diabetes epidemic. Popul Health Metr 2007; 5: 2.
29. Saydah SH, Geiss LS, Tierney ED, Benjamin SM, Engelgau M, Brancati F. Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol 2004; 14: 507-516.
30. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S537-542.